{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:43:41Z","timestamp":1784292221484,"version":"3.55.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cger.2021.01.006","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T16:15:03Z","timestamp":1616516103000},"page":"327-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chronic Immune-Mediated Polyneuropathies"],"prefix":"10.1016","volume":"37","author":[{"given":"Stephen Zachary","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly G.","family":"Gwathmey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cger.2021.01.006_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11940-019-0569-y","article-title":"Immune-mediated neuropathies","volume":"21","author":"Fadia","year":"2019","journal-title":"Curr Treat Options Neurol"},{"issue":"3\u20134","key":"10.1016\/j.cger.2021.01.006_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000494291","article-title":"Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis","volume":"52","author":"Broers","year":"2019","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mus.24068","article-title":"Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology","volume":"49","author":"Franssen","year":"2014","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.cger.2021.01.006_bib4","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"Kiefer","year":"2001","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1016\/j.cger.2021.01.006_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/mus.25253","article-title":"Postural tremor and chronic inflammatory demyelinating polyneuropathy","volume":"55","author":"Cao","year":"2017","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.cger.2021.01.006_bib7","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1212\/WNL.53.8.1648","article-title":"Fatigue in immune-mediated polyneuropathies. European inflammatory neuropathy cause and treatment (INCAT) group","volume":"53","author":"Merkies","year":"1999","journal-title":"Neurology"},{"issue":"Pt 6","key":"10.1016\/j.cger.2021.01.006_bib8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/brain\/110.6.1617","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases","volume":"110","author":"McCombe","year":"1987","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mus.26488","article-title":"Updated cerebrospinal fluid total protein reference values improve chronic inflammatory demyelinating polyneuropathy diagnosis","volume":"60","author":"Breiner","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cger.2021.01.006_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jns.2015.11.048","article-title":"Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies","volume":"360","author":"Lozeron","year":"2016","journal-title":"J\u00a0Neurol Sci"},{"issue":"8","key":"10.1016\/j.cger.2021.01.006_bib11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/14737175.2017.1340832","article-title":"Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan","volume":"17","author":"Nobile-Orazio","year":"2017","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"10.1016\/j.cger.2021.01.006_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.cger.2021.01.006_bib13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archneurol.2010.105","article-title":"Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"67","author":"Latov","year":"2010","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/ene.13218","article-title":"Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study","volume":"24","author":"Markvardsen","year":"2017","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","article-title":"Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"van Schaik","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib16","article-title":"Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews","author":"Oaklander","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.cger.2021.01.006_bib17","first-page":"2052","article-title":"Corticosteroids in chronic inflammatory demyelinating polyneuropathy\u202f: a retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone","volume":"265","author":"van Lieverloo","year":"2018","journal-title":"J\u00a0Neurol"},{"issue":"5","key":"10.1016\/j.cger.2021.01.006_bib18","article-title":"Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mahdi-Rogers","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cger.2021.01.006_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617746640","article-title":"Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies","volume":"11","author":"Dalakas","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ncl.2013.01.001","article-title":"Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol Clin"},{"issue":"8","key":"10.1016\/j.cger.2021.01.006_bib21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1474-4422(19)30144-9","article-title":"Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Bunschoten","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cger.2021.01.006_bib22","article-title":"Multifocal motor neuropathy: controversies and priorities","author":"Yeh","year":"2019","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"Pt 12","key":"10.1016\/j.cger.2021.01.006_bib23","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.cger.2021.01.006_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"10.1016\/j.cger.2021.01.006_bib25","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1212\/WNL.58.12.1856","article-title":"High-dose cyclophosphamide without stem-cell rescue for refractory CIDP","volume":"58","author":"Brannagan","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneurol.2011.175","article-title":"Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies","volume":"8","author":"Vlam","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.cger.2021.01.006_bib27","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1055\/s-0039-1688990","article-title":"Vasculitic neuropathies","volume":"39","author":"Beachy","year":"2019","journal-title":"Semin Neurol"},{"issue":"3","key":"10.1016\/j.cger.2021.01.006_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1529-8027.2010.00281.x","article-title":"Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary","volume":"15","author":"Collins","year":"2010","journal-title":"J\u00a0Peripher Nerv Syst"},{"issue":"5","key":"10.1016\/j.cger.2021.01.006_bib29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1212\/01.WNL.0000082715.48844.3E","article-title":"Nonsystemic vasculitic neuropathy: insights from a clinical cohort","volume":"61","author":"Collins","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.cger.2021.01.006_bib30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1600-0404.2006.00781.x","article-title":"Vasculitic neuropathy--electrodiagnostic findings and association with malignancies","volume":"115","author":"Zivkovi\u0107","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1468-1331.2010.03041.x","article-title":"The additional yield of combined nerve\/muscle biopsy in vasculitic neuropathy","volume":"18","author":"Vrancken","year":"2011","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.cger.2021.01.006_bib32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.55.5.636","article-title":"Superficial peroneal nerve\/peroneus brevis muscle biopsy in vasculitic neuropathy","volume":"55","author":"Collins","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ncl.2006.11.002","article-title":"Vasculitic neuropathies","volume":"25","author":"Burns","year":"2007","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(13)70236-9","article-title":"Vasculitic neuropathies","volume":"13","author":"Gwathmey","year":"2014","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.cger.2021.01.006_bib35","first-page":"461","article-title":"Necrotizing angiopathic neuropathy. Three-dimensional morphology of fiber degeneration related to sites of occluded vessels","volume":"47","author":"Dyck","year":"1972","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib36","first-page":"275","article-title":"Microsphere embolization of nerve capillaries and fiber degeneration","volume":"115","author":"Nukada","year":"1984","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/CND.0b013e3181b1eb6d","article-title":"Microvasculitis in diabetic lumbosacral radiculoplexus neuropathy","volume":"11","author":"Tracy","year":"2009","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0014-4886(85)90227-4","article-title":"Spatial distribution of capillaries in rat nerves: correlation to ischemic damage","volume":"87","author":"Nukada","year":"1985","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(89)90021-8","article-title":"Inner perineurial cell vulnerability in ischemia","volume":"489","author":"Benstead","year":"1989","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/mus.21639","article-title":"Direct immunofluoresence in vasculitic neuropathy: specificity of vascular immune deposits","volume":"42","author":"Collins","year":"2010","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.cger.2021.01.006_bib41","first-page":"633","article-title":"Primary and secondary vasculitic neuropathy","volume":"252","author":"Said","year":"2005","journal-title":"J\u00a0Neurol"},{"issue":"12","key":"10.1016\/j.cger.2021.01.006_bib42","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1474-4422(05)70249-0","article-title":"An update on the classification and treatment of vasculitic neuropathy","volume":"4","author":"Schaublin","year":"2005","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.cger.2021.01.006_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semarthrit.2015.03.004","article-title":"Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: case report and review of current clinical evidence","volume":"45","author":"Fanouriakis","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.cger.2021.01.006_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2003-41133","article-title":"Therapy of neurological disorders in systemic vasculitis","volume":"23","author":"Gold","year":"2003","journal-title":"Semin Neurol"},{"issue":"6","key":"10.1016\/j.cger.2021.01.006_bib47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11940-006-0002-1","article-title":"Therapy for vasculitic neuropathies","volume":"8","author":"Gorson","year":"2006","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"10.1016\/j.cger.2021.01.006_bib49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrneurol.2017.42","article-title":"The nonsystemic vasculitic neuropathies","volume":"13","author":"Collins","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/annrheumdis-2013-203883","article-title":"Hepatitis C virus-induced vasculitis: therapeutic options","volume":"73","author":"Cacoub","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.cger.2021.01.006_bib51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1525-1594.1995.tb02337.x","article-title":"Hepatitis C virus associated cryoglobulinemic neuropathy successfully treated with plasma exchange","volume":"19","author":"Murai","year":"1995","journal-title":"Artif Organs"},{"issue":"Suppl 1","key":"10.1016\/j.cger.2021.01.006_bib52","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/S1590-8658(07)80027-2","article-title":"Plasmapheresis in cryoglobulinemic neuropathy: a clinical study","volume":"39","author":"Scarpato","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.cger.2021.01.006_bib53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00296-007-0462-y","article-title":"Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab","volume":"28","author":"Braun","year":"2008","journal-title":"Rheumatol Int"},{"issue":"9813","key":"10.1016\/j.cger.2021.01.006_bib54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cger.2021.01.006_bib55","article-title":"Treatment for hepatitis C virus-associated mixed cryoglobulinaemia","author":"Montero","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib56","first-page":"289","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients","volume":"20","author":"Guillevin","year":"1993","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib57","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.berh.2015.05.007","article-title":"Vasculitis related to viral and other microbial agents","volume":"29","author":"Teng","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.cger.2021.01.006_bib58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cger.2021.01.006_bib59","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s11926-011-0214-6","article-title":"HIV infection and clinical spectrum of associated vasculitides","volume":"13","author":"Patel","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.cger.2021.01.006_bib60","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/s10165-009-0180-2","article-title":"Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sj\u00f6gren\u2019s syndrome","volume":"19","author":"Wakasugi","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"1\u20132","key":"10.1016\/j.cger.2021.01.006_bib61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2008.12.018","article-title":"Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sj\u00f6gren\u2019s syndrome","volume":"279","author":"Morozumi","year":"2009","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.cger.2021.01.006_bib62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40674-017-0076-9","article-title":"Neurological complications of Sj\u00f6gren\u2019s syndrome: diagnosis and management","volume":"3","author":"McCoy","year":"2017","journal-title":"Curr Treat Options Rheumatol"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib63","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/MJT.0000000000000583","article-title":"Immunoresponsive autonomic neuropathy in sj\u00f6gren syndrome-case series and literature review","volume":"26","author":"Goodman","year":"2019","journal-title":"Am J Ther"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib64","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/mus.24452","article-title":"Sensory ganglionopathy with livedoid vasculopathy controlled by immunotherapy","volume":"51","author":"Alix","year":"2015","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.20664","article-title":"Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial","volume":"35","author":"Gorson","year":"2007","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.cger.2021.01.006_bib66","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.autrev.2017.05.011","article-title":"Peripheral nervous system involvement in systemic lupus erythematosus: prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre","volume":"16","author":"Toledano","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cger.2021.01.006_bib67","article-title":"Short- and long-term outcome of systemic lupus erythematosus peripheral neuropathy: bimodal pattern of onset and treatment response","author":"Fargetti","year":"2019","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.cger.2021.01.006_bib68","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.cger.2021.01.006_bib69","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/art.1780381114","article-title":"Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients","volume":"38","author":"Pu\u00e9chal","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semarthrit.2006.04.006","article-title":"Systemic rheumatoid vasculitis: a review","volume":"36","author":"Genta","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cger.2021.01.006_bib71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.03.011","article-title":"Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment","volume":"126","author":"Tavee","year":"2017","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib72","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/brain\/awf027","article-title":"Nerve granulomas and vasculitis in sarcoid peripheral neuropathy. A clinicopathological study of 11 patients","volume":"125","author":"Said","year":"2002","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.cger.2021.01.006_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2006.01.014","article-title":"The natural history and long-term outcome of 57 limb sarcoidosis neuropathy cases","volume":"244","author":"Burns","year":"2006","journal-title":"J\u00a0Neurol Sci"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/sarh.2000.8364","article-title":"Sarcoidosis and systemic vasculitis","volume":"30","author":"Fernandes","year":"2000","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.cger.2021.01.006_bib75","first-page":"513","article-title":"The spectrum of nervous system involvement in Beh\u00e7et\u2019s syndrome and its differential diagnosis","volume":"256","author":"Siva","year":"2009","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.cger.2021.01.006_bib76","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1212\/CON.0000000000000523","article-title":"Immune axonal polyneuropathy","volume":"23","author":"Tavee","year":"2017","journal-title":"Continuum (Minneap Minn)"},{"issue":"5","key":"10.1016\/j.cger.2021.01.006_bib77","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.23821","article-title":"Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity?","volume":"48","author":"Ayrignac","year":"2013","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jns5.12053","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go","volume":"19","author":"Nobile-Orazio","year":"2014","journal-title":"J\u00a0Peripher Nerv Syst"},{"issue":"5","key":"10.1016\/j.cger.2021.01.006_bib79","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/WCO.0b013e328363bfa4","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options","volume":"26","author":"Eftimov","year":"2013","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10.1016\/j.cger.2021.01.006_bib80","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1388-2457(02)00011-1","article-title":"Can electrophysiology differentiate polyneuropathy with anti-MAG\/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?","volume":"113","author":"Capasso","year":"2002","journal-title":"Clin Neurophysiol"},{"issue":"9","key":"10.1016\/j.cger.2021.01.006_bib81","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/01.WNL.0000142507.12763.58","article-title":"Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia","volume":"63","author":"Sinnreich","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.cger.2021.01.006_bib82","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archneur.59.8.1333","article-title":"Prevalence of vasculitic neuropathy in Wegener granulomatosis","volume":"59","author":"Collins","year":"2002","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib83","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cger.2021.01.006_bib84","first-page":"1","article-title":"A\u00a0vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients","author":"Moosig","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib85","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1346-8138.2011.01316.x","article-title":"Elderly cases of Churg-Strauss syndrome: case report and review of Japanese cases","volume":"39","author":"Uchiyama","year":"2012","journal-title":"J\u00a0Dermatol"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib86","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.27240","article-title":"Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database","volume":"62","author":"Pagnoux","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.cger.2021.01.006_bib87","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ncl.2013.01.007","article-title":"The neuropathies of vasculitis","volume":"31","author":"Collins","year":"2013","journal-title":"Neurol Clin"},{"key":"10.1016\/j.cger.2021.01.006_bib88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-3-25","article-title":"Mixed cryoglobulinemia","volume":"3","author":"Ferri","year":"2008","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.cger.2021.01.006_bib89","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/acr.20381","article-title":"Hepatitis C virus-associated polyarteritis nodosa","volume":"63","author":"Saadoun","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.cger.2021.01.006_bib90","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semarthrit.2006.08.005","article-title":"Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases","volume":"36","author":"Ramos-Casals","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.cger.2021.01.006_bib91","first-page":"26","article-title":"[Peripheral nervous system involvement in HCV-related mixed cryoglobulinemia]","volume":"53","author":"Migliaresi","year":"2001","journal-title":"Reumatismo"},{"issue":"3","key":"10.1016\/j.cger.2021.01.006_bib92","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A\u00a0randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.cger.2021.01.006_bib93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11926-015-0545-9","article-title":"Drug-induced vasculitis: new insights and a changing lineup of suspects","volume":"17","author":"Grau","year":"2015","journal-title":"Curr Rheumatol Rep"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069021000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069021000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:56:36Z","timestamp":1760061396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069021000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0749069021000069"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2021.01.006","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Immune-Mediated Polyneuropathies","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2021.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}